PreveCeutical Medical advances gene therapy with BioGene Therapeutics to target diabetes and obesity
PreveCeutical's CEO and Chairman, Stephen Van Deventer, New to the Street Interview
PreveCeutical's Dr. Parekh and Dr. Khaled provide an update on our R&D programs
Network News Wire - Audio Interview with Stephen Van Deventer
Democracy in medicine - Financial Post Article
Proactive Investors Interview with Stephen Van Deventer - Video
Canadian med companies join to further research in Australia
PreveCeutical taps into wellness industry’s fastest growing segment
Gene Therapy Holds Out Hope for Diabetics
PreveCeutical seeing significant hospital interest for breakthrough Cannabidiol treatment - Video
A New Breakthrough in Cannabinoid Drug Delivery
Investment Opportunities in Advanced Bioengineered Drug Delivery
Promising New Approaches in Pain Management
Fast-Growing Cannabis Industry Drives Biotech Research, Innovative Medical Therapy Development
PreveCeutical Medical bidding to be big player in preventive healthcare
Market One Media/BNN interviews CEO Stephen Van Deventer - Video
PreveCeutical is poised for success with preventive health-care approach
Diabetes: Silence the Messenger, Don’t Shoot It!
Top 4 Companies Reinventing Cannabinoid Delivery
Entrepreneur “E-Radio” - Stephen Van Deventer Interview [00:18:21] - July 21, 2017
Winning the War on Diabetes & Obesity: a $2.5 Trillion Solution
PreveCeutical CEO Discusses Long-term Goals in Exclusive Interview
Multifaceted Biotech Company Poised to Begin Trading on Canadian Securities Exchange
How PreveCeutical Medical Wants to Own a $3.8 Trillion Industry — Q&A with CEO Stephen Van Deventer
Cannabis, scorpions, and synthesizing better drugs